Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HORF LOZENGES - HSA Drug Approval Details

Approvals/HSA/HORF LOZENGES

Approved

THERAPEUTIC

HORF LOZENGES

Y S P INDUSTRIES (M) SDN BHD (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Feb 5, 1996
Approval ID: e31e91e9bd9acabb
Company: Y S P INDUSTRIES (M) SDN BHD (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: e31e91e9bd9acabb
Drug Name: HORF LOZENGES
Product Name: HORF LOZENGES
Approval Number: SIN08535P
Approval Date: 1996-02-05
Registrant: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PHARMACY ONLY MEDICINES
Dosage Form: LOZENGE
Route Of Administration: ORAL
Atc Code: R02AA05
Atc Item Name: chlorhexidine
Pharma Manufacturer Name: YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Active Ingredients

CHLORHEXIDINE HCl

5 mg

BENZOCAINE

2 mg

BENZOCAINE

2 MG

CHLORHEXIDINE HCL

5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 5, 1996

Approval ID

e31e91e9bd9acabb

Type

Therapeutic

Back to HSA Approvals